Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer - Kantoff, Philip W.; Schuetz, Thomas J.; Blumenstein, Brent A.; Glode, L. Michael; Bilhartz, David L.; Wyand, Michael; Manson, Kelledy; Panicali, Dennis L.; Laus, Reiner; Schlom, Jeffrey; Dahut, William L.; Arlen, Philip M.; et al. (Journal of clinical oncology, 2010)
Keywords: Aged; Aged, 80 and over; Biological and medical sciences; Cancer Vaccines - immunology; Double-Blind Method; Genetic Vectors - immunology; Humans; Immunization; Male; Medical sciences; Middle Aged; Neoplasm Metastasis; Nephrology. Urinary tract diseases; Orchiectomy; Original Reports; Poxviridae - immunology; Prostate-Specific Antigen - antagonists & inhibitors; Prostate-Specific Antigen - immunology; Prostatic Neoplasms - mortality; Prostatic Neoplasms - pathology; Prostatic Neoplasms - therapy; Tumors; Tumors of the urinary system; Urinary tract. Prostate gland; Vaccines, Synthetic - immunology; Urinary system disease; Prostate disease; Targeting; Tumoral marker; Malignant tumor; Metastasis; Survival; Randomized controlled trial; Prostate specific antigen; Resistance; Cancerology; Treatment; Castration; Immunotherapy; Phase II trial; Advanced stage; Male genital diseases; Prostate cancer; Cancer